157 related articles for article (PubMed ID: 33891264)
1. Physiological MRI Biomarkers in the Differentiation Between Glioblastomas and Solitary Brain Metastases.
Heynold E; Zimmermann M; Hore N; Buchfelder M; Doerfler A; Stadlbauer A; Kremenevski N
Mol Imaging Biol; 2021 Oct; 23(5):787-795. PubMed ID: 33891264
[TBL] [Abstract][Full Text] [Related]
2. Vascular architecture mapping for early detection of glioblastoma recurrence.
Stadlbauer A; Eyüpoglu I; Buchfelder M; Dörfler A; Zimmermann M; Heinz G; Oberndorfer S
Neurosurg Focus; 2019 Dec; 47(6):E14. PubMed ID: 31786560
[TBL] [Abstract][Full Text] [Related]
3. Quantification of Radiomics features of Peritumoral Vasogenic Edema extracted from fluid-attenuated inversion recovery images in glioblastoma and isolated brain metastasis, using T1-dynamic contrast-enhanced Perfusion analysis.
Parvaze PS; Bhattacharjee R; Verma YK; Singh RK; Yadav V; Singh A; Khanna G; Ahlawat S; Trivedi R; Patir R; Vaishya S; Shah TJ; Gupta RK
NMR Biomed; 2023 May; 36(5):e4884. PubMed ID: 36453877
[TBL] [Abstract][Full Text] [Related]
4. Physiologic MR imaging of the tumor microenvironment revealed switching of metabolic phenotype upon recurrence of glioblastoma in humans.
Stadlbauer A; Oberndorfer S; Zimmermann M; Renner B; Buchfelder M; Heinz G; Doerfler A; Kleindienst A; Roessler K
J Cereb Blood Flow Metab; 2020 Mar; 40(3):528-538. PubMed ID: 30732550
[TBL] [Abstract][Full Text] [Related]
5. Differentiation of Glioblastoma and Solitary Brain Metastasis by Gradient of Relative Cerebral Blood Volume in the Peritumoral Brain Zone Derived from Dynamic Susceptibility Contrast Perfusion Magnetic Resonance Imaging.
She D; Xing Z; Cao D
J Comput Assist Tomogr; 2019; 43(1):13-17. PubMed ID: 30015801
[TBL] [Abstract][Full Text] [Related]
6. Differentiation between glioblastomas and brain metastases and regarding their primary site of malignancy using dynamic susceptibility contrast MRI at 3T.
Askaner K; Rydelius A; Engelholm S; Knutsson L; Lätt J; Abul-Kasim K; Sundgren PC
J Neuroradiol; 2019 Nov; 46(6):367-372. PubMed ID: 30389510
[TBL] [Abstract][Full Text] [Related]
7. Physiological MRI of microvascular architecture, neovascularization activity, and oxygen metabolism facilitate early recurrence detection in patients with IDH-mutant WHO grade 3 glioma.
Stadlbauer A; Heinz G; Oberndorfer S; Zimmermann M; Kinfe TM; Buchfelder M; Dörfler A; Kremenevski N; Marhold F
Neuroradiology; 2022 Feb; 64(2):265-277. PubMed ID: 34115146
[TBL] [Abstract][Full Text] [Related]
8. Single brain metastasis versus glioblastoma multiforme: a VOI-based multiparametric analysis for differential diagnosis.
Romano A; Moltoni G; Guarnera A; Pasquini L; Di Napoli A; Napolitano A; Espagnet MCR; Bozzao A
Radiol Med; 2022 May; 127(5):490-497. PubMed ID: 35316518
[TBL] [Abstract][Full Text] [Related]
9. Quantitative T1 mapping indicates tumor infiltration beyond the enhancing part of glioblastomas.
Nöth U; Tichy J; Tritt S; Bähr O; Deichmann R; Hattingen E
NMR Biomed; 2020 Mar; 33(3):e4242. PubMed ID: 31880005
[TBL] [Abstract][Full Text] [Related]
10. Histogram analysis of amide proton transfer-weighted imaging: comparison of glioblastoma and solitary brain metastasis in enhancing tumors and peritumoral regions.
Kamimura K; Nakajo M; Yoneyama T; Fukukura Y; Hirano H; Goto Y; Sasaki M; Akamine Y; Keupp J; Yoshiura T
Eur Radiol; 2019 Aug; 29(8):4133-4140. PubMed ID: 30488111
[TBL] [Abstract][Full Text] [Related]
11. Recurrence of glioblastoma is associated with elevated microvascular transit time heterogeneity and increased hypoxia.
Stadlbauer A; Mouridsen K; Doerfler A; Bo Hansen M; Oberndorfer S; Zimmermann M; Buchfelder M; Heinz G; Roessler K
J Cereb Blood Flow Metab; 2018 Mar; 38(3):422-432. PubMed ID: 28273720
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Peritumoral Brain Parenchyma Using Contrast-Enhanced 3D Fast Imaging Employing Steady-State Acquisition at 3T for Differentiating Metastatic Brain Tumors and Glioblastomas.
Yamamoto J; Kakeda S; Shimajiri S; Nakano Y; Saito T; Ide S; Moriya J; Korogi Y; Nishizawa S
World Neurosurg; 2018 Dec; 120():e719-e729. PubMed ID: 30165229
[TBL] [Abstract][Full Text] [Related]
13. Differentiation of glioblastoma multiforme, metastases and primary central nervous system lymphomas using multiparametric perfusion and diffusion MR imaging of a tumor core and a peritumoral zone-Searching for a practical approach.
Neska-Matuszewska M; Bladowska J; Sąsiadek M; Zimny A
PLoS One; 2018; 13(1):e0191341. PubMed ID: 29342201
[TBL] [Abstract][Full Text] [Related]
14. Development of a Non-invasive Assessment of Hypoxia and Neovascularization with Magnetic Resonance Imaging in Benign and Malignant Breast Tumors: Initial Results.
Stadlbauer A; Zimmermann M; Bennani-Baiti B; Helbich TH; Baltzer P; Clauser P; Kapetas P; Bago-Horvath Z; Pinker K
Mol Imaging Biol; 2019 Aug; 21(4):758-770. PubMed ID: 30478507
[TBL] [Abstract][Full Text] [Related]
15. Differentiation of glioblastomas from metastatic brain tumors by tryptophan uptake and kinetic analysis: a positron emission tomographic study with magnetic resonance imaging comparison.
Kamson DO; Mittal S; Buth A; Muzik O; Kupsky WJ; Robinette NL; Barger GR; Juhász C
Mol Imaging; 2013; 12(5):327-37. PubMed ID: 23759373
[TBL] [Abstract][Full Text] [Related]
16. Tumor-related Perfusion Changes in White Matter Adjacent to Brain Tumors: Pharmacodynamic Analysis of Dynamic 3T Magnetic Resonance Imaging.
Tupý R; Mírka H; Mraček J; Přibáň V; Hes O; Vokurka S; Ferda J
Anticancer Res; 2018 Jul; 38(7):4149-4152. PubMed ID: 29970543
[TBL] [Abstract][Full Text] [Related]
17. Predicting Glioblastoma Response to Bevacizumab Through MRI Biomarkers of the Tumor Microenvironment.
Stadlbauer A; Roessler K; Zimmermann M; Buchfelder M; Kleindienst A; Doerfler A; Heinz G; Oberndorfer S
Mol Imaging Biol; 2019 Aug; 21(4):747-757. PubMed ID: 30361791
[TBL] [Abstract][Full Text] [Related]
18. Magnetic Resonance Imaging Features of Rhabdoid Glioblastomas.
Gelal MF; Rezanko TA; Sarp AF; Dirilenoğlu F; Güvenç G; Ölmezoğlu A
Clin Neuroradiol; 2016 Sep; 26(3):329-40. PubMed ID: 25516148
[TBL] [Abstract][Full Text] [Related]
19. Intratumoral heterogeneity of oxygen metabolism and neovascularization uncovers 2 survival-relevant subgroups of IDH1 wild-type glioblastoma.
Stadlbauer A; Zimmermann M; Doerfler A; Oberndorfer S; Buchfelder M; Coras R; Kitzwögerer M; Roessler K
Neuro Oncol; 2018 Oct; 20(11):1536-1546. PubMed ID: 29718366
[TBL] [Abstract][Full Text] [Related]
20. IDH genotypes differentiation in glioblastomas using DWI and DSC-PWI in the enhancing and peri-enhancing region.
Xing Z; Zhang H; She D; Lin Y; Zhou X; Zeng Z; Cao D
Acta Radiol; 2019 Dec; 60(12):1663-1672. PubMed ID: 31084193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
